Corrigan Financial’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-8,891
| Closed | -$326K | – | 66 |
|
|
2023
Q2 | $326K | Buy |
8,891
+8
| +0.1% | +$311 | 0.1% | 56 |
|
|
2023
Q1 | $362K | Sell |
8,883
-207
| -2% | -$8.94K | 0.12% | 53 |
|
|
2022
Q4 | $466K | Sell |
9,090
-1,601
| -15% | -$76.8K | 0.17% | 40 |
|
|
2022
Q3 | $468K | Buy |
10,691
+18
| +0.2% | +$875 | 0.18% | 41 |
|
|
2022
Q2 | $560K | Sell |
10,673
-3,775
| -26% | -$192K | 0.2% | 38 |
|
|
2022
Q1 | $748K | Buy |
14,448
+3,808
| +36% | +$198K | 0.24% | 37 |
|
|
2021
Q4 | $628K | Buy |
10,640
+683
| +7% | +$33.8K | 0.18% | 42 |
|
|
2021
Q3 | $428K | Sell |
9,957
-189
| -2% | -$8.37K | 0.13% | 50 |
|
|
2021
Q2 | $397K | Buy |
10,146
+14
| +0.1% | +$544 | 0.12% | 54 |
|
|
2021
Q1 | $367K | Buy |
10,132
+1,064
| +12% | +$37.8K | 0.12% | 51 |
|
|
2020
Q4 | $334K | Sell |
9,068
-490
| -5% | -$18K | 0.15% | 47 |
|
|
2020
Q3 | $333K | Hold |
9,558
| – | – | 0.17% | 42 |
|
|
2020
Q2 | $297K | Sell |
9,558
-99
| -1% | -$3.36K | 0.16% | 42 |
|
|
2020
Q1 | $299K | Sell |
9,657
-39
| -0.4% | -$1.33K | 0.22% | 39 |
|
|
2019
Q4 | $360K | Sell |
9,696
-2,754
| -22% | -$98.1K | 0.25% | 35 |
|
|
2019
Q3 | $424K | Buy |
12,450
+2,741
| +28% | +$99.7K | 0.32% | 24 |
|
|
2019
Q2 | $399K | Sell |
9,709
-493
| -5% | -$19.6K | 0.3% | 26 |
|
|
2019
Q1 | $411K | Buy |
10,202
+295
| +3% | +$11.8K | 0.3% | 34 |
|
|
2018
Q4 | $410K | Buy |
9,907
+497
| +5% | +$20.6K | 0.33% | 23 |
|
|
2018
Q3 | $393K | Sell |
9,410
-176
| -2% | -$6.78K | 0.28% | 28 |
|
|
2018
Q2 | $330K | Buy |
9,586
+1,392
| +17% | +$47.6K | 0.25% | 29 |
|
|
2018
Q1 | $276K | Buy |
8,194
+714
| +10% | +$24.5K | 0.21% | 33 |
|
|
2017
Q4 | $257K | Sell |
7,480
-1,465
| -16% | -$50K | 0.22% | 38 |
|
|
2017
Q3 | $303K | Buy |
8,945
+1,136
| +15% | +$36.5K | 0.27% | 33 |
|
|
2017
Q2 | $249K | Buy |
7,809
+826
| +12% | +$26K | 0.23% | 36 |
|
|
2017
Q1 | $227K | Hold |
6,983
| – | – | 0.22% | 34 |
|
|
2016
Q4 | $215K | Buy |
6,983
+71
| +1% | +$2.17K | 0.21% | 36 |
|
|
2016
Q3 | $222K | Hold |
6,912
| – | – | 0.22% | 34 |
|
|
2016
Q2 | $231K | Sell |
6,912
-764
| -10% | -$24.4K | 0.24% | 34 |
|
|
2016
Q1 | $216K | Buy |
7,676
+574
| +8% | +$16.4K | 0.22% | 42 |
|
|
2015
Q4 | $217K | Buy |
+7,102
| New | +$223K | 0.23% | 30 |
|
Other funds holding PFE
Corrigan Financial's PFE Position: Q3 2023 in Review
Corrigan Financial sold out of Pfizer (PFE) in Q3 2023, closing a stake of 8,891 shares — an estimated $326K sold.
Corrigan Financial first reported a position in PFE in Q4 2015 and held it in 31 quarters. The position peaked at $748K in Q1 2022. 2,926 funds tracked by Wall St. Rank hold PFE as of Q3 2023.
- Corrigan Financial reported no remaining Pfizer position as of Q3 2023 after selling out during the quarter.
- Corrigan Financial sold 8,891 Pfizer shares in Q3 2023, an estimated $326K.
- Corrigan Financial first reported a position in Pfizer in Q4 2015 and held it in 31 quarters.
- Corrigan Financial's Pfizer position peaked at $748K in Q1 2022.
- 2,926 funds tracked by Wall St. Rank held Pfizer as of Q3 2023.
Based on Corrigan Financial's 13F filing for Q3 2023, filed 16 Oct 2023.